CareCloud Files 8-K/A Amendment
Ticker: CCLDO · Form: 8-K/A · Filed: Oct 31, 2025 · CIK: 1582982
| Field | Detail |
|---|---|
| Company | Carecloud, Inc. (CCLDO) |
| Form Type | 8-K/A |
| Filed Date | Oct 31, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, filing, regulatory
Related Tickers: CCLD
TL;DR
CareCloud filed an amendment to an 8-K. No new info, just a cleanup.
AI Summary
CareCloud, Inc. filed an amendment (8-K/A) on October 31, 2025, to its report originally dated August 22, 2025. This amendment pertains to financial statements and exhibits, with no specific financial figures or new material events detailed in the provided text.
Why It Matters
This filing indicates an update or correction to a previous report, suggesting ongoing regulatory compliance and transparency from CareCloud, Inc.
Risk Assessment
Risk Level: low — The filing is an amendment to a previous report and does not introduce new financial risks or material changes.
Key Players & Entities
- CareCloud, Inc. (company) — Registrant
- MTBC, Inc. (company) — Former company name
- MEDICAL TRANSCRIPTION BILLING, CORP (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
FAQ
What is the purpose of this 8-K/A filing?
This filing is an amendment (Amendment No. 1) to a previous 8-K report, specifically concerning financial statements and exhibits.
When was the original report filed or effective?
The earliest event reported was August 22, 2025, and the filing date of the amendment is October 31, 2025.
What is CareCloud, Inc.'s state of incorporation?
CareCloud, Inc. is incorporated in Delaware.
What were CareCloud, Inc.'s former names?
CareCloud, Inc. was formerly known as MTBC, Inc. and MEDICAL TRANSCRIPTION BILLING, CORP.
Does this amendment introduce new financial information or material events?
The provided text for the 8-K/A filing does not detail specific new financial information or material events beyond indicating it's an amendment for financial statements and exhibits.
Filing Stats: 673 words · 3 min read · ~2 pages · Grade level 10.3 · Accepted 2025-10-31 17:00:35
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share CCLD Nasdaq Global Market
Filing Documents
- form8-ka.htm (8-K/A) — 49KB
- ex23-1.htm (EX-23.1) — 3KB
- ex99-1.htm (EX-99.1) — 832KB
- ex99-2.htm (EX-99.2) — 175KB
- ex99-3.htm (EX-99.3) — 389KB
- ex99-4.htm (EX-99.4) — 87KB
- 0001493152-25-020427.txt ( ) — 1853KB
- ccld-20250822.xsd (EX-101.SCH) — 4KB
- ccld-20250822_def.xml (EX-101.DEF) — 26KB
- ccld-20250822_lab.xml (EX-101.LAB) — 36KB
- ccld-20250822_pre.xml (EX-101.PRE) — 25KB
- form8-ka_htm.xml (XML) — 7KB
Financial statements of businesses or funds acquired
Financial statements of businesses or funds acquired. The financial statements of Medsphere are filed as Exhibit 99.1 and Exhibit 99.2 to this Form 8-K and incorporated by reference herein. (b) Pro forma financial information. Pro forma financial information with respect to the acquisition of Medsphere is filed as Exhibit 99.3 to this Form 8-K and incorporated by reference herein. ( d) Exhibits 23.1 Consent of Tanner LLC. 99.1 Audited financial statements of Medsphere as of December 31, 2024 and 2023 and for the years then ended. 99.2 Unaudited interim financial statements of Medsphere as of June 30, 2025 and for the six months then ended. 99.3 Unaudited pro forma condensed combined financial information with respect to the acquisitions of Medsphere, RevNu and Mesa (a) as of June 30, 2025, (b) for the six months ended June 30, 2025 and (c) for the year ended December 31, 2024. 99.4 Supplemental information. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 3
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CareCloud, Inc. Date: October 31, 2025 By: /s/ Norman Roth Norman Roth Interim Chief Financial Officer and Corporate Controller 4